文献速递神经MR

阿尔茨海默病中的脑脊液β淀粉样蛋白、Tau蛋白、载脂蛋白与质子磁共振波谱脑代谢物:一项系统综述

Cerebrospinal Fluid Amyloid Beta, Tau Levels, Apolipoprotein, and 1H-MRS Brain Metabolites in Alzheimer's Disease: A Systematic Review.
PubMed 文献 · Acad Radiol · 2020-07-07

该系统综述纳入24篇文章,分析阿尔茨海默病中质子磁共振波谱所测神经化学改变及其与脑脊液生物标志物和APOE ε4的关系。结果显示后扣带回/楔前叶NAA、NAA/Cr、NAA/ml降低,ml、ml/Cr、Cho/Cr、ml/NAA升高;ml与tau升高相关,NAA/Cr降低与tau升高相关,ml/Cr与Aβ42负相关、与t-tau正相关;APOE ε4携带者NAA和谷胱甘肽降低。作者认为NAA、ml及其比值可能是潜在生物标志物,需大型纵向研究阐明APOE ε4对脑代谢物的影响。

要点

  • 后扣带回/楔前叶NAA、NAA/Cr、NAA/ml降低,ml、ml/Cr、Cho/Cr、ml/NAA升高。
  • ml升高与tau升高相关,NAA/Cr降低与tau升高相关。
  • ml/Cr与Aβ42负相关、与t-tau正相关;APOE ε4携带者NAA和谷胱甘肽降低。

关键影像表现/征象

  • 后扣带回/楔前叶NAA、NAA/Cr、NAA/ml降低。
  • 后扣带回/楔前叶ml、ml/Cr、Cho/Cr、ml/NAA升高。
  • APOE ε4携带者NAA和谷胱甘肽水平降低。
  • APOE ε4对NAA/Cr无调节作用。
  • APOE ε4、Aβ42与ml/Cr之间存在交互作用。

诊断标准与关键数值

  • ml升高与tau升高相关。
  • NAA/Cr降低与tau升高相关。
  • ml/Cr与Aβ42呈负相关。
  • ml/Cr与t-tau呈正相关。
  • NAA、ml、NAA/Cr、NAA/ml和ml/Cr可能是突出AD临床阶段功能变化的潜在生物标志物。

临床应用与阅片要点

  • 作者认为NAA、ml、NAA/Cr、NAA/ml和ml/Cr可能是潜在生物标志物,可能突出AD临床阶段的功能变化。
  • 作者认为ml与tau、NAA/Cr与Aβ42、NAA/Cr与tau的组合可能支持区分MCI/AD与健康个体的诊断过程。
  • 作者指出需大型纵向研究阐明APOE ε4对脑代谢物的影响。

局限性

  • 需大型纵向研究阐明APOE ε4对脑代谢物的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: There is compelling evidence that neurochemical changes measured by proton magnetic resonance spectroscopy (1H-MRS) occur at different phases of Alzheimer's disease (AD). However, the extent to which these neurochemical changes are associated with validated AD biomarkers and/or apolipoprotein (APOE) ε4 is yet to be established.

OBJECTIVE: This systematic review analyzed the available evidence on (1) neurochemical changes; and (2) the relations between brain metabolite and validated cerebrospinal fluid biomarkers, and/or APOE in AD.

METHODS: PubMed, Cochrane, Scopus, and gray literature were systematically screened for studies deemed fit for the purpose of the current systematic review.

RESULTS: Twenty four articles met the inclusion criteria. Decreased levels of N-acetyl aspartate (NAA), NAA/(creatine) Cr, and NAA/(myo-inositol) ml, and increased ml, ml/Cr, Cho (choline)/Cr, and ml/NAA were found in the posterior cingulate cortex/precuneus. Increased ml is associated with increased tau levels, reduced NAA/Cr is associated with increased tau. ml/Cr is negatively correlated with Aβ42, and ml/Cr is positively correlated with t-tau. NAA and glutathione levels are reduced in APOE ε4 carriers. APOE ε4 exerts no modulatory effect on NAA/Cr. There is interaction between APOE ε4, Aβ42, and ml/Cr.

CONCLUSION: NAA, ml, NAA/Cr, NAA/ml and ml/Cr may be potentially useful biomarkers that may highlight functional changes in the clinical stages of AD. The combinations of ml and tau, NAA/Cr and Aβ42, and NAA/Cr and tau may support the diagnostic process of differentiating MCI/AD from healthy individuals. Large, longitudinal studies are required to clarify the effect of APOE ε4 on brain metabolites.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Piersson AD, Mohamad M, Rajab F, et al. Cerebrospinal Fluid Amyloid Beta, Tau Levels, Apolipoprotein, and 1H-MRS Brain Metabolites in Alzheimer's Disease: A Systematic Review. Acad Radiol. 2020. PMID: 32651050. doi:10.1016/j.acra.2020.06.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。